JP2018502909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502909A5 JP2018502909A5 JP2017551388A JP2017551388A JP2018502909A5 JP 2018502909 A5 JP2018502909 A5 JP 2018502909A5 JP 2017551388 A JP2017551388 A JP 2017551388A JP 2017551388 A JP2017551388 A JP 2017551388A JP 2018502909 A5 JP2018502909 A5 JP 2018502909A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- reaction mixture
- reaction
- aqueous phase
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094580P | 2014-12-19 | 2014-12-19 | |
| US62/094,580 | 2014-12-19 | ||
| PCT/IB2015/059741 WO2016098054A1 (en) | 2014-12-19 | 2015-12-17 | Processes for preparing oxathiazin-like compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019206621A Division JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502909A JP2018502909A (ja) | 2018-02-01 |
| JP2018502909A5 true JP2018502909A5 (enExample) | 2019-12-26 |
| JP6746605B2 JP6746605B2 (ja) | 2020-08-26 |
Family
ID=55077556
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017551388A Active JP6746605B2 (ja) | 2014-12-19 | 2015-12-17 | オキサチアジン様化合物を作製する方法 |
| JP2019206621A Active JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
| JP2021184435A Active JP7449913B2 (ja) | 2014-12-19 | 2021-11-12 | オキサチアジン様化合物を作製する方法 |
| JP2023202330A Active JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019206621A Active JP7030093B2 (ja) | 2014-12-19 | 2019-11-15 | オキサチアジン様化合物を作製する方法 |
| JP2021184435A Active JP7449913B2 (ja) | 2014-12-19 | 2021-11-12 | オキサチアジン様化合物を作製する方法 |
| JP2023202330A Active JP7688098B2 (ja) | 2014-12-19 | 2023-11-30 | オキサチアジン様化合物を作製する方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10392355B2 (enExample) |
| EP (2) | EP4011871A3 (enExample) |
| JP (4) | JP6746605B2 (enExample) |
| KR (1) | KR102594322B1 (enExample) |
| CN (3) | CN107257786B (enExample) |
| AU (2) | AU2015365348B2 (enExample) |
| CA (1) | CA2971570A1 (enExample) |
| CY (1) | CY1125047T1 (enExample) |
| DK (1) | DK3233813T3 (enExample) |
| ES (1) | ES2907592T3 (enExample) |
| HR (1) | HRP20220313T1 (enExample) |
| HU (1) | HUE058257T2 (enExample) |
| IL (1) | IL252912B (enExample) |
| LT (1) | LT3233813T (enExample) |
| MX (2) | MX392353B (enExample) |
| PL (1) | PL3233813T3 (enExample) |
| PT (1) | PT3233813T (enExample) |
| RS (1) | RS62955B1 (enExample) |
| SI (1) | SI3233813T1 (enExample) |
| SM (1) | SMT202200091T1 (enExample) |
| WO (1) | WO2016098054A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11591302B2 (en) * | 2014-12-19 | 2023-02-28 | Geistlich Pharm A Ag | Processes for preparing oxathiazin-like compounds |
| ES2907592T3 (es) * | 2014-12-19 | 2022-04-25 | Geistlich Pharma Ag | Procesos para preparar compuestos de tipo oxatiazina |
| EP3440064B1 (en) * | 2016-04-07 | 2020-05-13 | Geistlich Pharma AG | Process for preparing oxathiazin-like compounds |
| WO2018155706A1 (ja) * | 2017-02-27 | 2018-08-30 | 株式会社シード探索研究所 | 抗真菌組成物 |
| CN109602744A (zh) * | 2018-12-13 | 2019-04-12 | 中国人民解放军总医院 | 荜茇酰胺在制备抗菌消炎药物中的应用 |
| US12514847B2 (en) | 2019-05-22 | 2026-01-06 | Geistlich Pharma Ag | Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release |
| WO2020234829A1 (en) * | 2019-05-22 | 2020-11-26 | Geistlich Pharma Ag | Methods and compositions for inhibiting gapdh |
| WO2020234828A1 (en) * | 2019-05-22 | 2020-11-26 | Geistlich Pharma Ag | Oxathiazin compounds for inhibiting gapdh |
| CN111617086A (zh) * | 2020-07-06 | 2020-09-04 | 长春迈灵生物工程有限公司 | 牛磺罗定在制备抗hpv病毒药物中的应用 |
| CN111671758A (zh) * | 2020-07-06 | 2020-09-18 | 长春迈灵生物工程有限公司 | 牛磺罗定在制备抗hiv病毒药物中的应用 |
| JP7752675B2 (ja) * | 2020-07-06 | 2025-10-10 | アカデミー オブ ミリタリー メディカル サイエンシズ | ウイルスに対するタウロリジンの使用 |
| IL307990A (en) * | 2021-04-29 | 2023-12-01 | Geistlich Pharma Ag | Antimicrobial and anticancer agents |
| CN118724762A (zh) * | 2024-06-24 | 2024-10-01 | 湖南增达生物科技有限公司 | 一种牛磺酸的制备新工艺 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1160443B (de) | 1961-11-30 | 1964-01-02 | Hoechst Ag | Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden |
| GB1124285A (en) * | 1964-10-06 | 1968-08-21 | Geistlich Soehne Ag | Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them |
| DE1234988B (de) | 1964-11-28 | 1967-02-23 | Bayer Ag | Verfahren zur Herstellung von Copolymerisaten des Trioxans |
| DK167393B1 (da) * | 1985-12-30 | 1993-10-25 | Roussel Uclaf | 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf |
| GB8617482D0 (en) | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| IT1296926B1 (it) * | 1997-12-05 | 1999-08-03 | Zambon Spa | Procedimento per la preparazione di composti ad attivita' antimicotica |
| WO2006033446A1 (en) * | 2004-09-21 | 2006-03-30 | Astellas Pharma Inc. | Aminoalcohol derivatives |
| US20080275032A1 (en) | 2006-12-29 | 2008-11-06 | Yuefen Zhou | Pyridazinone compounds |
| JP2008222659A (ja) | 2007-03-14 | 2008-09-25 | Asahi Kasei Corp | スルホンアミド化合物の製造方法 |
| TW200911245A (en) * | 2007-06-07 | 2009-03-16 | Astellas Pharma Inc | Pyridone derivatives |
| US8088824B2 (en) | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
| US20120142676A1 (en) * | 2010-08-18 | 2012-06-07 | Gaik-Lean Chee | Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules |
| EP2643308B1 (en) * | 2010-11-23 | 2016-08-17 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of taurolidine and its intermediates thereof |
| ES2644870T3 (es) * | 2012-06-18 | 2017-11-30 | Geistlich Pharma Ag | Derivados de oxatiazina como agentes antibacterianos y anticancerígenos |
| ES2907592T3 (es) | 2014-12-19 | 2022-04-25 | Geistlich Pharma Ag | Procesos para preparar compuestos de tipo oxatiazina |
-
2015
- 2015-12-17 ES ES15821172T patent/ES2907592T3/es active Active
- 2015-12-17 EP EP21211288.2A patent/EP4011871A3/en active Pending
- 2015-12-17 MX MX2019013194A patent/MX392353B/es unknown
- 2015-12-17 WO PCT/IB2015/059741 patent/WO2016098054A1/en not_active Ceased
- 2015-12-17 SM SM20220091T patent/SMT202200091T1/it unknown
- 2015-12-17 US US15/535,266 patent/US10392355B2/en active Active
- 2015-12-17 PT PT158211722T patent/PT3233813T/pt unknown
- 2015-12-17 CA CA2971570A patent/CA2971570A1/en active Pending
- 2015-12-17 KR KR1020177019296A patent/KR102594322B1/ko active Active
- 2015-12-17 EP EP15821172.2A patent/EP3233813B1/en active Active
- 2015-12-17 HU HUE15821172A patent/HUE058257T2/hu unknown
- 2015-12-17 RS RS20220195A patent/RS62955B1/sr unknown
- 2015-12-17 CN CN201580072835.0A patent/CN107257786B/zh active Active
- 2015-12-17 PL PL15821172T patent/PL3233813T3/pl unknown
- 2015-12-17 AU AU2015365348A patent/AU2015365348B2/en active Active
- 2015-12-17 HR HRP20220313TT patent/HRP20220313T1/hr unknown
- 2015-12-17 LT LTEPPCT/IB2015/059741T patent/LT3233813T/lt unknown
- 2015-12-17 CN CN202310038641.5A patent/CN119454714A/zh active Pending
- 2015-12-17 SI SI201531791T patent/SI3233813T1/sl unknown
- 2015-12-17 DK DK15821172.2T patent/DK3233813T3/da active
- 2015-12-17 MX MX2017008112A patent/MX369462B/es active IP Right Grant
- 2015-12-17 JP JP2017551388A patent/JP6746605B2/ja active Active
- 2015-12-17 CN CN201910974314.4A patent/CN110776479A/zh active Pending
-
2017
- 2017-06-14 IL IL252912A patent/IL252912B/en active IP Right Grant
-
2019
- 2019-08-12 US US16/538,344 patent/US10968190B2/en active Active
- 2019-11-05 AU AU2019261702A patent/AU2019261702B2/en active Active
- 2019-11-15 JP JP2019206621A patent/JP7030093B2/ja active Active
-
2021
- 2021-11-12 JP JP2021184435A patent/JP7449913B2/ja active Active
-
2022
- 2022-03-04 CY CY20221100186T patent/CY1125047T1/el unknown
-
2023
- 2023-11-30 JP JP2023202330A patent/JP7688098B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502909A5 (enExample) | ||
| JP2022031717A5 (enExample) | ||
| CN106866553A (zh) | 一种法匹拉韦的合成方法 | |
| JP2022060192A5 (enExample) | ||
| JP2009062360A (ja) | シナカルセットの製造方法 | |
| WO2012037764A1 (zh) | （e）-2-[2-（6-氯嘧啶-4-基氧）苯基]-3-甲氧基丙烯酸甲酯的制备方法 | |
| WO2015111085A2 (en) | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof | |
| JP5485138B2 (ja) | エチニルチミジン化合物の精製方法 | |
| JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| CN104876812B (zh) | 制备盐酸舍曲林中间体及杂质的方法 | |
| CN105585564A (zh) | 恩曲他滨的纯化方法 | |
| CN104817546B (zh) | 一种奥美沙坦酯母液回收的方法 | |
| CN103724248B (zh) | 维格列汀工艺杂质的制备方法 | |
| WO2013149364A1 (zh) | 一种1-羟甲基环丙基乙腈合成方法 | |
| CN102702196B (zh) | 3-甲基-7-氮杂吲哚的合成方法 | |
| CN105503787A (zh) | 一种索非布韦中间体的纯化方法 | |
| JP6287290B2 (ja) | ｔｒａｎｓ−１，２−ジアミノシクロヘキサンの製造方法 | |
| CN105669539B (zh) | 一种2-氨基-3-氟吡啶的制备工艺 | |
| WO2021127965A1 (zh) | 一种伏立康唑对映异构体的回收方法 | |
| CN103880730A (zh) | 一种7-硝基吲哚-3-甲酸叔丁酯的化学合成方法 | |
| CN111635368B (zh) | 一种胺化合物的制备方法 | |
| JP2012513391A5 (enExample) | ||
| CN102766137B (zh) | 一种高纯度伊拉地平的制备方法 | |
| CN100534989C (zh) | (rs)-苯并二噁烷-2-甲酸的拆分方法 | |
| JPWO2003057665A1 (ja) | ベンゼンスルホンアミド誘導体結晶の製造方法、およびその中間体の新規結晶とその製造方法 |